New Preclinical Data Demonstrate Favorable Oral Bioavailability, Robust Brain Penetration and Liver Exposure with ...
A new intranasal DNA vaccine may give the immune system an extra weapon against tuberculosis by targeting bacteria that can ...
InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV) The Company is assessing the most efficient ...
Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an exclusive licensing agreement with Nuvectis, a U.S. biotechnology company. Under the agreement, Haisco ...
Summary: Patients surviving severe traumatic brain injuries often enter states designated as Prolonged Disorders of ...
Cemdisiran could be the first siRNA approved for the treatment of gMG and only therapy to be offered subcutaneously with four times a year dosing ...
In 1939, he repeatedly placed dog ticks on guinea pigs and watched something change. After the first round of bites, the ...
A new kind of partnership between human and machine is beginning to reshape how stroke recovery may look in the future.
Investors are betting that a deeper understanding of the brain will allow BCI systems to address the significant unmet need affecting millions of people with neurological disorders. They are also ...
Researchers from the German Cancer Research Center (DKFZ), the HI-STEM* Stem Cell Institute and Heidelberg University ...
Detailed price information for China Medical System Holdings Ltd (CHSYF) from The Globe and Mail including charting and trades.
Vietnam Investment Review on MSN
Nona Biosciences Lonza develop blood brain barrier crossing antibody platform for CNS
CAMBRIDGE, Mass., July 2, 2026 /PRNewswire/ -- Nona Biosciences ("Nona"), a global biotechnology company advancing biologics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results